Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/08/22
End: 05/29/26
Due: 05/29/27
Phase: N/A
Priority: Normal
Start: 08/24/23
End: 07/29/26
Due: 07/29/27
Phase: N/A
Priority: Normal
Start: 07/18/23
End: 07/10/26
Due: 07/10/27
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Safety,Tolerability,and Pharmacokinetics Profiles of GB001 Recombinant Peptide Spray in Healthy Subjects | NCT05125211 | Zhejiang Echon Biopharm Limited | user2@example.com | None | 2022-08-08 | 2026-05-29 | 2027-05-29 | - | - | 2025-07-14 |
| Safety, Tolerability, Pharmacokinetics and Immunogenicity Study of GB002 Recombinant Peptide Inhalation Solution in Healthy Subjects | NCT06423261 | Zhejiang Echon Biopharm Limited | user2@example.com | None | 2023-08-24 | 2026-07-29 | 2027-07-29 | - | - | 2025-07-14 |
| Safety and Efficacy Study of GB001 Recombinant Peptide Spray in Subjects With Mild Recurrent Aphthous Ulcers | NCT06429566 | Zhejiang Echon Biopharm Limited | user2@example.com | None | 2023-07-18 | 2026-07-10 | 2027-07-10 | - | - | 2025-07-14 |